Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Sonodynamic Therapy Explained
View:
Post by made2last on Jul 18, 2023 7:30am

Sonodynamic Therapy Explained

Hi All;

Sonodynamic Therapy Explained 

https://en.m.wikipedia.org/wiki/Sonodynamic_therapy


T
hanks;

made2last
Comment by Lesalpes29 on Jul 18, 2023 7:34am
Very promissing for tlt. GL
Comment by ScienceFirst on Jul 18, 2023 11:41am
Nice posts Pandora and Made2last on SonoTherapy that TLT is aiming for, in order to treat deep-seated tumors with our metal complex PDCs.   SONODYNAMIC THERAPY USING SONODYNAMICALLY ACTIVATED COORDINATION COMPLEXES OF TRANSITION METALS AS SENSITIZING AGENTS Publication number: 20220296709 Abstract: A method for destroying cells and/or ...more  
Comment by 99942Apophis on Jul 18, 2023 1:05pm
That would change the revenue stream for Theralase!  If as said  So, after PDT, that would be our 2nd way of taken advantage of the amazing potency of our PDCs to destroy tumors, no matter where they are in the body, for example in deep-seated tissues/organs. In 2020 worldwide Bladder cancer patients were 573,000 and 75% of that was 430,000 for NMIBC if sonodynamic treatment could ...more  
Comment by DeathXray33 on Jul 18, 2023 2:50pm
"$50,000 per treatment" $150,000 per treatment x 2 for $300,000 total x 14,300 ?
Comment by ScienceFirst on Jul 18, 2023 3:16pm
99942Apophis ... TLT already demonstrated in 2017 that they can handle MIBC with PDT. Sonotherapy would rather be for other type of indications.
Comment by 99942Apophis on Jul 18, 2023 3:45pm
Thanks ScienceFirst,  that makes it even more exciting. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250